Results 321 to 330 of about 303,848 (355)
Some of the next articles are maybe not open access.
Dopamine Receptor Oligomerization
2009Each dopamine (DA) receptor subtype physically interacts with its own kind (homomers) or other receptors (heteromers) in the plasma membrane of neurons in the basal ganglia to form dimeric or high-order receptor oligomers, termed dimeric or high-order receptor mosaics (RMs).
Fuxe K +4 more
openaire +3 more sources
Vascular Dopamine and Dopamine Receptor Agonists
1984Regulation and modulation of the sympathetic nervous system have been and remain cornerstone strategies for the treatment of cardiovascular disease. Whereas stimulating, mimicking or antagonizing norepinephrine and epinphrine have been the most frequently utilized approach to cardiovascular renal therapeutics, the possibility that dopamine and dopamine
Robert W. Erickson +3 more
openaire +2 more sources
Characterization of Dopamine Receptors
Current Protocols in Pharmacology, 1998AbstractDopamine receptors are the principal targets of drugs used for the treatment of neuropsychiatric disorders such as schizophrenia and Parkinson's disease. This unit details protocols for radioligand binding assays for various subtypes of dopamine receptor.
openaire +3 more sources
Neostriatal dopamine receptors
Trends in Neurosciences, 1990De Keyser, Jacques, Ebinger, Guy
openaire +4 more sources
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
Dopamine receptors and schizophrenia [PDF]
Biochemical Society Transactions, 1996 openaire +2 more sources